Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

689
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
689
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

7.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.4K
Coagulation01:09

Coagulation

6.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.4K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

5.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.7K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

777
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
777
Disorders of Hemostasis01:24

Disorders of Hemostasis

881
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
881

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Molecular mechanisms of naturally encoded signaling bias at the complement anaphylatoxin receptors.

Molecular cell·2026
Same author

Asking AI About Your Car: AI-Augmented Vehicle Owner's Manuals Support Integrated System Understanding Beyond Traditional Documentation.

Human factors·2026
Same author

Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities.

Trends in pharmacological sciences·2026
Same author

With a Little Help From My Car: Sharing Automated Vehicle's Situation Awareness Reduces Driver-Initiated Automation Disengagement Without Delaying Takeover Response Time.

Human factors·2026
Same author

Complement-mediated and direct activation of human neutrophils induced by <i>Premolis semirufa</i> caterpillar toxins.

Frontiers in immunology·2026
Same author

Consumption of processed foods impairs memory function through dietary advanced glycation end-products.

bioRxiv : the preprint server for biology·2026
Same journal

IL-33 scripts cancer immunity.

Trends in immunology·2026
Same journal

Mitochondrial Ca<sup>2+</sup> signaling: A metabolic rheostat defining tumor and immune cell fate.

Trends in immunology·2026
Same journal

Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinations.

Trends in immunology·2026
Same journal

Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease.

Trends in immunology·2026
Same journal

Metabolic regulatory nodes of the inflammasome and inflammatory cell death.

Trends in immunology·2026
Same journal

Parental leave in immunology - 6.

Trends in immunology·2026
查看所有相关文章

相关实验视频

Updated: Jun 28, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.9K

补充了长期COVID的血栓炎症和病变发生.

John D Lee1, Trent M Woodruff2

  • 1School of Biomedical Sciences, University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.

Trends in immunology
|April 18, 2024
PubMed
概括
此摘要是机器生成的。

长期COVID是SARS-CoV-2感染后的一种持续性疾病,涉及复杂的免疫反应. 研究揭示了补体和凝血系统之间的联系,受抗病毒抗体和组织损伤的影响,为这个具有挑战性的健康问题提供了洞察力.

关键词:
这就是SARS-CoV-2病毒.凝血是凝固的过程.补充补充补充补充补充补充补充.这是一种炎症炎症炎症炎症.长时间的COVID.

更多相关视频

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.7K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K

相关实验视频

Last Updated: Jun 28, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.9K
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.7K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K

科学领域:

  • 免疫学 免疫学 免疫学
  • 传染性疾病 传染性疾病
  • 病理生理学 病理生理学

背景情况:

  • 长期COVID的特点是SARS-CoV-2感染后持续的症状,这对全球健康构成了重大挑战.
  • 了解长期COVID的潜在免疫机制对于开发有效治疗方法至关重要.

研究的目的:

  • 为了研究长期COVID患者的免疫学情景.
  • 在长期COVID的背景下,探索补充和凝固系统之间的相互作用.

主要方法:

  • 这项研究分析了长期COVID患者的免疫标记.
  • 研究了抗病毒抗体和组织损伤在疾病发病过程中的作用.

主要成果:

  • 在长期COVID患者中,补充和凝血通路之间表现出显著的相互作用.
  • 确定了抗病毒抗体和组织损伤是这种免疫失调的关键驱动因素.

结论:

  • 这些发现突出了复杂的免疫学相互作用,有助于长期COVID.
  • 建议准补充和凝血通路可能为长期COVID管理提供治疗策略.